GSK celebrates US FDA backing for expanded use of cancer drug Jemperli
(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration expanded the use of its cancer medicine Jemperli, also known as dostarlimab, when combined with chemotherapy. Read More